A Long Term Safety Study With Atrasentan

Clinical trial NCT00127478 · COMPLETED

Trial details

NCT number: NCT00127478
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Prostate Cancer Adenocarcinoma

Start date: 2001-07-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.